Cargando…

Targeting Thyroid Cancer Microenvironment: Basic Research and Clinical Applications

Detalles Bibliográficos
Autor principal:	Nucera, Carmelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816219/ https://www.ncbi.nlm.nih.gov/pubmed/24204363 http://dx.doi.org/10.3389/fendo.2013.00167

Ejemplares similares

Clinical Outcome, Role of BRAF(V600E), and Molecular Pathways in Papillary Thyroid Microcarcinoma: Is It an Indolent Cancer or an Early Stage of Papillary Thyroid Cancer?
por: Nucera, Carmelo, et al.
Publicado: (2012)

The Role of Primary Cilia in Thyroid Cancer: From Basic Research to Clinical Applications
por: Ma, Cheng-Xu, et al.
Publicado: (2021)

Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells with BRAF(V600E): New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment
por: Duquette, Mark, et al.
Publicado: (2013)

Corrigendum: Thrombospondin-1 Silencing Down-Regulates Integrin Expression Levels in Human Anaplastic Thyroid Cancer Cells With BRAF(V600E): New Insights in the Host Tissue Adaptation and Homeostasis of Tumor Microenvironment
por: Duquette, Mark, et al.
Publicado: (2020)

Clonal Reconstruction of Thyroid Cancer: An Essential Strategy for Preventing Resistance to Ultra-Precision Therapy
por: McGonagle, Elizabeth R., et al.
Publicado: (2019)

Targeting BRAF(V600E) with PLX4720 Displays Potent Antimigratory and Anti-invasive Activity in Preclinical Models of Human Thyroid Cancer
por: Nucera, Carmelo, et al.
Publicado: (2011)

Editorial: Novel insights into sperm function and selection: from basic research to clinical application
por: Li, Kun, et al.
Publicado: (2023)

A novel combined targeted therapy with bromodomain antagonist and MEK inhibitor in anaplastic thyroid cancer
por: Nucera, Carmelo
Publicado: (2019)

Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player?
por: Rotondi, Mario, et al.
Publicado: (2018)

Application of CRISPR-Cas9 gene editing technology in basic research, diagnosis and treatment of colon cancer
por: Meng, Hui, et al.
Publicado: (2023)

Evolution of resistance to thyroid cancer therapy
por: Nucera, Carmelo
Publicado: (2016)

Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment
por: Xie, Zhenyu, et al.
Publicado: (2020)

Editorial: Translational Research in Thyroid Cancer
por: Vasko, Vasyl, et al.
Publicado: (2020)

Identification of a Recurrence Signature and Validation of Cell Infiltration Level of Thyroid Cancer Microenvironment
por: Zhang, Liang, et al.
Publicado: (2020)

Role of Regulatory Non-Coding RNAs in Aggressive Thyroid Cancer: Prospective Applications of Neural Network Analysis
por: Iesato, Asumi, et al.
Publicado: (2021)

Interleukins in Thyroid Cancer: From Basic Researches to Applications in Clinical Practice
por: Xi, Chuang, et al.
Publicado: (2020)

Editorial: Double-edged swords: Important factors connecting metabolic disorders and cancer development – from basic research to translational applications
por: Kung, Che-Pei, et al.
Publicado: (2023)

Targeting Endothelin-1 Receptor/β-Arrestin-1 Axis in Ovarian Cancer: From Basic Research to a Therapeutic Approach
por: Tocci, Piera, et al.
Publicado: (2019)

Construction of a Tumor Immune Microenvironment-Related Prognostic Model in BRAF-Mutated Papillary Thyroid Cancer
por: Xia, Yuxiao, et al.
Publicado: (2022)

The role of lactate metabolism-related LncRNAs in the prognosis, mutation, and tumor microenvironment of papillary thyroid cancer
por: Xia, Minqi, et al.
Publicado: (2023)

Editorial: Translational research in thyroid cancer, Volume II
por: Cheng, Sheue-yann, et al.
Publicado: (2023)

Molecular Targeted Therapies of Aggressive Thyroid Cancer
por: Ferrari, Silvia Martina, et al.
Publicado: (2015)

Update on Targeted Therapy in Medullary Thyroid Cancer
por: Okafor, Christian, et al.
Publicado: (2021)

Editorial: Targeted therapy in advanced thyroid cancer
por: Boucai, Laura
Publicado: (2022)

Thyroid cancer cell lines: Critical models to study thyroid cancer biology and new therapeutic targets
por: Schweppe, Rebecca E.
Publicado: (2012)

Adipose-Derived Stem Cells for the Treatment of Diabetic Wound: From Basic Study to Clinical Application
por: Liu, Runzhu, et al.
Publicado: (2022)

Targeting the Metastatic Bone Microenvironment by MicroRNAs
por: Haider, Marie-Therese, et al.
Publicado: (2018)

Calculated Parameters of Thyroid Homeostasis: Emerging Tools for Differential Diagnosis and Clinical Research
por: Dietrich, Johannes W., et al.
Publicado: (2016)

Editorial: The clinical application and progress of precise diagnosis and treatment of thyroid tumors
por: Tang, Jiajia, et al.
Publicado: (2023)

Intracellular Signal Transduction and Modification of the Tumor Microenvironment Induced by RET/PTCs in Papillary Thyroid Carcinoma
por: Menicali, Elisa, et al.
Publicado: (2012)

Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment
por: Guo, Mengli, et al.
Publicado: (2021)

Target Therapy in Thyroid Cancer: Current Challenge in Clinical Use of Tyrosine Kinase Inhibitors and Management of Side Effects
por: Puliafito, Ivana, et al.
Publicado: (2022)

Futures Challenges in Thyroid Hormone Signaling Research
por: Flamant, Frédéric
Publicado: (2016)

Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis
por: Hescheler, Daniel A., et al.
Publicado: (2021)

Actions of Thyroid Hormones on Thyroid Cancers
por: Mousa, Shaker A., et al.
Publicado: (2021)

STRA6 regulates tumor immune microenvironment and is a prognostic marker in BRAF-mutant papillary thyroid carcinoma
por: He, Weiman, et al.
Publicado: (2023)

Global research landscape and trends of papillary thyroid cancer therapy: a bibliometric analysis
por: Song, Bo, et al.
Publicado: (2023)

Effect of the micronutrient iodine in thyroid carcinoma angiogenesis
por: Daniell, Kayla, et al.
Publicado: (2016)

Research progress on moyamoya disease combined with thyroid diseases
por: Zhang, Guibo, et al.
Publicado: (2023)

Editorial: Clinical and Molecular Epidemiology of Thyroid Cancer of Follicular Origin
por: Malaguarnera, Roberta, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_58ptkv7igdk42qhmmua5gqj363